# Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease

> **NCT01917721** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Hawaii Pacific Health** · enrollment: 50 (estimated)

## Conditions studied

- Kawasaki Disease
- Coronary Aneurysm

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01917721
- **Lead sponsor:** Hawaii Pacific Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-10
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01917721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01917721, "Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01917721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*